Penny Stocks
EVAX: Evaxion Approaches a Cancer-Vaccine Data Test
Upcoming follow-up data for Evaxion’s personalized cancer vaccine provide a clear event to watch. The investment question is what the evidence can establish, and what a small study cannot.
Read the story